Azacyclic FTY720 Analogues That Limit Nutrient Transporter Expression but Lack S1P Receptor Activity and Negative Chronotropic Effects Offer a Novel and Effective Strategy to Kill Cancer Cells in Vivo.
about
Attacking the supply wagons to starve cancer cells to death.Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways.Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation.Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
P2860
Azacyclic FTY720 Analogues That Limit Nutrient Transporter Expression but Lack S1P Receptor Activity and Negative Chronotropic Effects Offer a Novel and Effective Strategy to Kill Cancer Cells in Vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Azacyclic FTY720 Analogues Tha ...... to Kill Cancer Cells in Vivo.
@en
type
label
Azacyclic FTY720 Analogues Tha ...... to Kill Cancer Cells in Vivo.
@en
prefLabel
Azacyclic FTY720 Analogues Tha ...... to Kill Cancer Cells in Vivo.
@en
P2093
P2860
P1433
P1476
Azacyclic FTY720 Analogues Tha ...... to Kill Cancer Cells in Vivo.
@en
P2093
Aimee L Edinger
Alison N McCracken
Andrea Huwiler
Andrew Keebaugh
Daniel Fallegger
Elizabeth Selwan
Michael T Kleinman
Rebecca Fransson
Ryan J McMonigle
P2860
P304
P356
10.1021/ACSCHEMBIO.5B00761
P577
2015-12-14T00:00:00Z